Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2016 Apr 29. pii: S0167-8140(16)31018-0. doi: 10.1016/j.radonc.2016.03.011
    Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
    Sturdza A1,  Pötter R2,  Fokdal LU3,  Haie-Meder C4,  Tan LT5,  Mazeron R6,  Petric P7,  Šegedin B8,  Jurgenliemk-Schulz IM9,  Nomden C10,  Gillham C11,  McArdle O12,  Van Limbergen E13,  Janssen H14,  Hoskin P15,  Lowe G16,  Tharavichitkul E17,  Villafranca E18,  Mahantshetty U19,  Georg P20,  Kirchheiner K21,  Kirisits C22,  Tanderup K23,  Lindegaard JC24
    Author information
    1Medical University of Vienna, Comprehensive Cancer Center, Department of Radiation Oncology, Austria.
    2Medical University of Vienna, Comprehensive Cancer Center, Department of Radiation Oncology, Austria. Electronic address: richard.poetter@meduniwien.ac.at.
    3Aarhus University Hospital, Department of Oncology, Denmark.
    4Gustave Roussy Cancer Campus Grand Paris, Department of Radiation Oncology, Villejuif, France.
    5Cambridge University Addenbrooke's Hospital, Department of Radiotherapy, United Kingdom.
    6Gustave Roussy Cancer Campus Grand Paris, Department of Radiation Oncology, Villejuif, France.
    7Institute of Oncology Ljubljana, Division of Radiotherapy, Slovenia.
    8Institute of Oncology Ljubljana, Division of Radiotherapy, Slovenia.
    9University Medical Center Utrecht, Department of Radiotherapy, The Netherlands.
    10University Medical Center Utrecht, Department of Radiotherapy, The Netherlands.
    11St Luke's Hospital, Dublin, Ireland.
    12St Luke's Hospital, Dublin, Ireland.
    13Department of Radiotherapy, University Hospital Gasthuisberg, Leuven, Belgium.
    14Department of Radiotherapy, University Hospital Gasthuisberg, Leuven, Belgium.
    15Mount Vernon Hospital, Department of Radiotherapy, London, United Kingdom.
    16Mount Vernon Hospital, Department of Radiotherapy, London, United Kingdom.
    17Faculty of Medicine, Chiang Mai University, Thailand.
    18University of Navarra, Department of Oncology, Pamplona, Spain.
    19Tata Memorial Hospital, Mumbai, India.
    20Medical University of Vienna, Comprehensive Cancer Center, Department of Radiation Oncology, Austria.
    21Medical University of Vienna, Comprehensive Cancer Center, Department of Radiation Oncology, Austria.
    22Medical University of Vienna, Comprehensive Cancer Center, Department of Radiation Oncology, Austria.
    23Aarhus University Hospital, Department of Oncology, Denmark.
    24Aarhus University Hospital, Department of Oncology, Denmark.
    Abstract

    PURPOSE: Image guided brachytherapy (IGBT) for locally advanced cervical cancer allows dose escalation to the high-risk clinical target volume (HRCTV) while sparing organs at risk (OAR). This is the first comprehensive report on clinical outcome in a large multi-institutional cohort.

    PATIENTS AND METHODS: From twelve centres 731 patients, treated with definitive EBRT±concurrent chemotherapy followed by IGBT, were analysed. Kaplan-Meier estimates at 3/5years were calculated for local control (LC, primary endpoint), pelvic control (PC), overall survival (OS), cancer specific survival (CSS). In 610 patients, G3-4 late toxicity (CTCAEv3.0) was reported.

    RESULTS: Median follow up was 43months, percent of patients per FIGO stage IA/IB/IIA 22.8%, IIB 50.4%, IIIA-IVB 26.8%. 84.8% had squamous cell carcinomas; 40.5% lymph node involvement. Mean EBRT dose was 46±2.5Gy; 77.4% received concurrent chemotherapy. Mean D90 HRCTV was 87±15Gy (EQD210), mean D2cc was: bladder 81±22Gy, rectum 64±9Gy, sigmoid 66±10Gy and bowel 64±9Gy (all EQD23). The 3/5-year actuarial LC, PC, CSS, OS were 91%/89%, 87%/84%, 79%/73%, 74%/65%. Actuarial LC at 3/5years for IB, IIB, IIIB was 98%/98%, 93%/91%, 79%/75%. Actuarial PC at 3/5years for IB, IIB, IIIB was 96%/96%, 89%/87%, 73%/67%. Actuarial 5-year G3-G5 morbidity was 5%, 7%, 5% for bladder, gastrointestinal tract, vagina.

    CONCLUSION: IGBT combined with radio-chemotherapy leads to excellent LC (91%), PC (87%), OS (74%), CSS (79%) with limited severe morbidity.


    Copyright © 2016. Published by Elsevier Ireland Ltd.

    KEYWORDS: Image guided brachytherapy, Locally advanced cervical cancer, Outcome

    Publikations ID: 27134181
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt